HomeTagsCalytrix Bio

Tag: Calytrix Bio

Eli Lilly agrees to acquire...

Eli Lilly and Company has entered into...

Eli Lilly agrees to acquire Calytrix Bio for up to $1.5 billion

Eli Lilly and Company has entered into a definitive agreement to acquire privately held biotechnology company Calytrix Bio, Inc. in a transaction valued at up to $1.5 billion in cash. The deal adds a preclinical antibody programme targeting mutant calreticulin (mCALR) to Lilly's pipeline for myeloproliferative neoplasms (MPNs), including essential thrombocythemia and myelofibrosis. Under the agreement, Calytrix shareholders may receive an upfront payment followed by additional payments linked to the achievement of clinical and regulatory milestones. The upfront amount and expected closing date have not been disclosed. A preclinical antibody targeting...

Eli Lilly agrees...

Eli Lilly and Company has entered into a definitive agreement to acquire privately held biotechnology company Calytrix Bio, Inc. in a transaction valued at...
spot_img

Create a website from scratch

With Newspaper Theme you can drag and drop elements onto a page and customize them to perfection. Try it out today and create the perfect site to express yourself!